Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-20-076871

Options or other derivatives

  • Director acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Swirsky Douglas J Director 2020-06-24 Grant or award · Stock option (right to buy) +80,000 80,000 D
Loading xslF345X03/tm2023456d3_4.xml…